Abiopharma

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

MoneyHero Officially Launches Credit Hero Club in Hong Kong, Powered by TransUnion

MoneyHero在香港正式推出Credit Hero Club 並由環聯提供服務

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Grupo Aeroportuario del Pacifico Provides Update on the Impact of Hurricane Melissa in Jamaica

Raytech Holding Limited Announces 16 for 1 Share Consolidation

Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

TeraWulf Inc. Announces Upsize and Pricing of $900 Million Convertible Notes Offering

Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants

Chapman Steven Leonard 🔴 sold 6.0K shares of Natera, Inc. (NTRA) at $192.32 ($1.2M) Transaction Date: Oct 27, 2025 | Filing ID: 000008

Brophy Michael Burkes 🔴 sold 5.1K shares of Natera, Inc. (NTRA) at $192.32 Transaction Date: Oct 27, 2025 | Filing ID: 000009

New Form SCHEDULE 13D/A - Avidity Biosciences, Inc. Filed: 2025-10-29 AccNo: 0001493215-25-000013 Size: 25 KB

Athabasca Oil Announces 2025 Third Quarter Results Highlighted by Consistent Operational Performance, Continued Share Buybacks and a Pristine Financial Position

Sheena Jonathan 🔴 sold 479 shares of Natera, Inc. (NTRA) at $192.32 Transaction Date: Oct 27, 2025 | Filing ID: 000012